semaglutide diarrhea lawsuit in louisiana Woman sues drug makers of Ozempic and Mounjaro over severe gastrointestinal issues semaglutide gi obstruction lawyer in

Hepatotoxicity affects roughly 1 in 5,000 users, usually within the first 6 weeks of treatment, causing jaundice, dark urine, and severe fatigueparticularly dangerous in patients over 65

These are temporary and may resolve independently in a few days or weeks

At every meal, eat protein first before moving to other foods

Plenty of people continue their GLP-1 medications successfully after gallbladder surgery, with the right medical guidance

Wegovy , a higher-dose version, is specifically approved for obesity and delivers stronger appetite suppression

In the SURMOUNT-1 trial, approximately 6-7% of patients discontinued Zepbound specifically due to gastrointestinal adverse events